AU2002310654A1 - Bursal disease virus-like particles - Google Patents
Bursal disease virus-like particlesInfo
- Publication number
- AU2002310654A1 AU2002310654A1 AU2002310654A AU2002310654A AU2002310654A1 AU 2002310654 A1 AU2002310654 A1 AU 2002310654A1 AU 2002310654 A AU2002310654 A AU 2002310654A AU 2002310654 A AU2002310654 A AU 2002310654A AU 2002310654 A1 AU2002310654 A1 AU 2002310654A1
- Authority
- AU
- Australia
- Prior art keywords
- particles
- disease virus
- bursal disease
- bursal
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10041—Use of virus, viral particle or viral elements as a vector
- C12N2720/10045—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0105858A FR2824327B1 (fr) | 2001-05-02 | 2001-05-02 | Particules pseudovirales de birnavirus |
FR01/05858 | 2001-05-02 | ||
PCT/FR2002/001482 WO2002088339A2 (fr) | 2001-05-02 | 2002-04-29 | Particules pseudovirales de birnavirus |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002310654A1 true AU2002310654A1 (en) | 2002-11-11 |
Family
ID=8862894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002310654A Abandoned AU2002310654A1 (en) | 2001-05-02 | 2002-04-29 | Bursal disease virus-like particles |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002310654A1 (fr) |
FR (1) | FR2824327B1 (fr) |
WO (1) | WO2002088339A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2217967B1 (es) * | 2003-03-31 | 2006-01-01 | Consejo Sup. Investig. Cientificas | Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv. |
ES2307346B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
ES2307345B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
ES2310062B1 (es) * | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
EP2093281A1 (fr) * | 2008-02-19 | 2009-08-26 | Kapsid Link, S.L. | Nanoporteurs de protéines, procédé pour les obtenir et applications |
PL2288618T3 (pl) | 2008-05-09 | 2018-02-28 | Chimera Pharma S.L.U. | Chimeryczne białka fuzyjne oraz cząstki wirusopodobne z białka vp2 birnawirusa |
WO2011054995A2 (fr) * | 2009-11-06 | 2011-05-12 | Chimera Pharma, S. L. U. | Vaccins prophylactiques contre la grippe obtenus à partir de capsides virales de birnavirus contenant l'antigène m2e du virus de la grippe |
CN102145166B (zh) * | 2011-04-21 | 2013-05-22 | 江苏省农业科学院 | 重组禽流感M2e的鸡传染性法氏囊VP2亚单位疫苗、其构建方法及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0222842B1 (fr) * | 1985-05-30 | 1995-05-10 | Commonwealth Scientific And Industrial Research Organisation | Clonage et expression des immunogenes protecteurs d'hote du virus de la bursite infectieuse (ibdv) |
EP0332677B1 (fr) * | 1987-07-27 | 1995-07-19 | Syntro Corporation | Virus d'herpes attenues, virus d'herpes comprenant de l'adn etranger de codage d'une sequence d'acides amines et vaccins les contenant |
CA2110505A1 (fr) * | 1991-07-26 | 1993-02-18 | Enzo Paoletti | Vaccin poxvirus recombinant contre le virus de la bursite infectieuse |
US6231868B1 (en) * | 1997-09-30 | 2001-05-15 | University Of Maryland-Biotechnology Institute | Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts |
-
2001
- 2001-05-02 FR FR0105858A patent/FR2824327B1/fr not_active Expired - Fee Related
-
2002
- 2002-04-29 WO PCT/FR2002/001482 patent/WO2002088339A2/fr not_active Application Discontinuation
- 2002-04-29 AU AU2002310654A patent/AU2002310654A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002088339A3 (fr) | 2004-01-22 |
FR2824327B1 (fr) | 2003-07-11 |
WO2002088339A2 (fr) | 2002-11-07 |
FR2824327A1 (fr) | 2002-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002367748A1 (en) | Infectious disease microarray | |
AU2002236159A1 (en) | Immunogenic complex | |
AU2002336760A1 (en) | Mutable vaccines | |
AU2003293294A1 (en) | Uv-stabilised particles | |
AU2002323023A1 (en) | Multipurpose pillow assembly | |
AU2002359163A1 (en) | New use | |
AUPQ912000A0 (en) | Improved virus like particles | |
AU2002254558A1 (en) | Novel vaccine | |
AU2002341877A1 (en) | Lysin-deficient bacteriophages having reduced immunogenicity | |
AU2002322059A1 (en) | Improved vaccination against anthrax | |
AU2002349543A1 (en) | Tumor antigens | |
AU2001283862A1 (en) | Bvdv virus-like particles | |
AU2002310654A1 (en) | Bursal disease virus-like particles | |
GB0201382D0 (en) | Virus-like particles | |
AU2002367108A1 (en) | Dna vaccine for periodontal disease | |
AU2003227026A1 (en) | An infectious bursal disease virus variant | |
AU2002367423A1 (en) | Hard capsules | |
AU2002346252A1 (en) | Particle probe | |
AU2002236065A1 (en) | Papillomavirus vaccines | |
AU2003237701A1 (en) | Vaccines | |
AU2002347346A1 (en) | Dna vaccine | |
AU2003237906A1 (en) | Virus-like particles | |
AU2002337263A1 (en) | Anti-coronavirus vaccine | |
AUPR440001A0 (en) | Vaccine | |
AU2002319485A1 (en) | Dna vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |